FDA Approved Cobenfy for Schizophrenia
This is a news story, published by Yahoo, that relates primarily to Cobenfy news.
Cobenfy news
For more Cobenfy news, you can click here:
more Cobenfy newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo news
For more news from Yahoo, you can click here:
more news from YahooAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
other antipsychotic schizophrenia medications. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Current antipsychotic medications news, antipsychotic medications news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
other antipsychotic medicationsVerywell Health
•Cobenfy: The First New Schizophrenia Drug in Decades
81% Informative
Cobenfy (xanomeline and trospium chloride) targets a different neurotransmitter to indirectly influence dopamine levels.
Cobenf is the first new schizophrenia treatment in over 30 years .
It reduces both positive and negative schizophrenia symptoms, with side effects compared to current medications.
The FDA approved the drug without a boxed warning, which usually accompanies antipsychotics.
Cobenfy will be available in October at a list price of $ 1,850 per month before insurance and rebates.
The company said that the price is in line with other antipsychotic schizophrenia medications.
The drug may also be useful as a treatment for Bipolar I disorder and Alzheimer's disease agitation.
VR Score
76
Informative language
73
Neutral language
54
Article tone
formal
Language
English
Language complexity
68
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
9
Affiliate links
no affiliate links